Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A severe form of Netherton syndrome caused by a specific gene mutation led to neonatal deaths in a family.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

The new model helps understand and develop treatments for genetic skin disorders like AEC.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

WNT10A gene mutations cause short anagen hair syndrome.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

New treatments for diabetes, central nervous system repair, and cartilage injury were found, and a way to create functional hair follicles from stem cells was developed.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Glutamic acid microneedle patches promote better hair growth than traditional treatments.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

A new mutation in the HR gene causes hair loss in a specific family.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

UTX is crucial for skin differentiation and health, especially in females.

Abrocitinib may effectively treat stubborn alopecia universalis.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.